The benefit of prothrombin complex concentrate in decreasing neurological deterioration in patients with warfarin-associated intracerebral haemorrhage.
OBJECTIVE
To compare the outcomes of patients with warfarin-associated intracerebral haemorrhage given different treatments to reverse the effect of anticoagulation.


METHODS
Historical cohort study.


METHODS
A regional hospital in Hong Kong.


METHODS
Patients on warfarin who developed intracerebral haemorrhage.


METHODS
Prothrombin complex concentrate versus fresh frozen plasma treatment.


METHODS
The primary outcome measures included the international normalised ratio before and after prothrombin complex concentrate treatment and the neurological deterioration in patients with Glasgow Coma Scale score of more than 8/not intubated/not planned for immediate surgery (target group). Secondary outcome measures were haematoma expansion, 7-day and 30-day mortality rates, and 3-month functional outcome. Safety outcome was the occurrence of a thrombotic event after prothrombin complex concentrate treatment within the index admission.


RESULTS
Among 33 patients with clearly documented time of infusion of prothrombin complex concentrate, and whose international normalised ratio was checked before and after prothrombin complex concentrate treatment, the mean international normalised ratio was reduced from 2.81 to 1.21 within 24 hours. Within the target group of patients, there was a significantly lower rate of neurological deterioration in the prothrombin complex concentrate group (17.4% of 23 patients) versus fresh frozen plasma group (45.5% of 33 patients) [P=0.027]. In terms of the 7-day mortality, 30-day mortality, and 3-month functional outcome, prothrombin complex concentrate-treated group showed a favourable trend although the difference did not reach a statistical significance. No patient developed thrombotic complications after prothrombin complex concentrate treatment.


CONCLUSIONS
Prothrombin complex concentrates can reverse the warfarin effect of prolonged international normalised ratio in a timely manner. It might better improve the outcome of warfarin-associated intracerebral haemorrhage compared with fresh frozen plasma treatment by reduction in neurological deterioration.
Division of Neurology, Department of Medicine, Queen Elizabeth Hospital, Jordan, Hong Kong.
W C
WC
Fong
Division of Neurology, Department of Medicine, Queen Elizabeth Hospital, Jordan, Hong Kong.
W T
WT
Lo
Division of Neurology, Department of Medicine, Queen Elizabeth Hospital, Jordan, Hong Kong.
Y W
YW
Ng
Division of Neurology, Department of Medicine, Queen Elizabeth Hospital, Jordan, Hong Kong.
Y F
YF
Cheung
Department of Accident and Emergency, Queen Elizabeth Hospital, Jordan, Hong Kong.
Gordon C K
GC
Wong
Department of Accident and Emergency, Queen Elizabeth Hospital, Jordan, Hong Kong.
H F
HF
Ho
Division of Neurology, Department of Medicine, Queen Elizabeth Hospital, Jordan, Hong Kong.
John H M
JH
Chan
Division of Neurology, Department of Medicine, Queen Elizabeth Hospital, Jordan, Hong Kong.
Patrick C K
PC
Li
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects; D001779:Blood Coagulation Factors / Q000008:administration & dosage*; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000188:drug therapy* / Q000401:mortality; D004636:Emergency Service, Hospital; D005260:Female; D015600:Glasgow Coma Scale; D006723:Hong Kong; D006761:Hospitals; D006801:Humans; D008297:Male; D010949:Plasma; D012189:Retrospective Studies; D016896:Treatment Outcome; D014859:Warfarin / Q000009:adverse effects
D000925:Anticoagulants; D001779:Blood Coagulation Factors; C025667:prothrombin complex concentrates; D014859:Warfarin
Intracranial hemorrhages; Nervous system diseases; Warfarin